Cargando…
Inhibition of KMO Ameliorates Myocardial Ischemia Injury via Maintaining Mitochondrial Fusion and Fission Balance
Looking for early diagnostic markers and therapeutic targets is the key to ensuring prompt treatment of myocardial ischemia (MI). Here, a novel biomarker xanthurenic acid (XA) was identified based on metabolomics and exhibited high sensitivity and specificity in the diagnosis of MI patients. Additio...
Autores principales: | Lai, Qiong, Wu, Lingling, Dong, Shuhong, Zhu, Xiaozhou, Fan, Zhaoyang, Kou, Junping, Liu, Fuming, Yu, Boyang, Li, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321280/ https://www.ncbi.nlm.nih.gov/pubmed/37416768 http://dx.doi.org/10.7150/ijbs.83392 |
Ejemplares similares
-
Omentin1 ameliorates myocardial ischemia-induced heart failure via SIRT3/FOXO3a-dependent mitochondrial dynamical homeostasis and mitophagy
por: Hu, Jingui, et al.
Publicado: (2022) -
Ruscogenin Alleviates Myocardial Ischemia-Induced Ferroptosis through the Activation of BCAT1/BCAT2
por: Fu, Fei, et al.
Publicado: (2022) -
Cardioprotection by combination of three compounds from ShengMai preparations in mice with myocardial ischemia/reperfusion injury through AMPK activation-mediated mitochondrial fission
por: Li, Fang, et al.
Publicado: (2016) -
Kynurenine catabolic enzyme KMO regulates HCC growth
por: Shi, Zhaopeng, et al.
Publicado: (2022) -
KMO in the promotion of tumor development and progression in hepatocellular carcinoma
por: Xu, Jun, et al.
Publicado: (2023)